- In April 2023, Cipla Inc. successfully raised $50 million in funding in April 2023 to develop a series of dermatological products, including a novel treatment for dandruff. This funding will support the research and development of products that are more effective and have fewer side effects than existing treatments
- In February 2023, AstraZeneca launched a new scalp treatment cream that reduces dandruff and soothes scalp irritation. This product introduction is part of a larger strategy to diversify their dermatological offerings, aiming to capture a 20% increase in their skincare market share
- In June 2022, Procter & Gamble, introduced a new line of anti-dandruff shampoos under its existing brand, featuring advanced formulations that target the root cause of dandruff. This launch is expected to bolster their sales by 15%, focusing on a blend of efficacy and consumer trust in their products